Top Sell
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €4.44 | - | - |
| Vaxart Inc. | 0 | 1 | 0 | 0 | €0.66 | - | - |
| Applied Therapeutics Inc | 1 | 1 | 0 | 0 | €4.49 | €4.00 | -10.834% |
| Sage Therapeutics Inc. | 5 | 3 | 0 | 0 | €11.05 | €26.71 | 141.763% |
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €7.05 | €58.50 | 729.787% |
| Gritstone Oncology Inc | 2 | 2 | 0 | 0 | €0.73 | €6.53 | 792.213% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.50 | €3.00 | 506.061% |
| D.Western Therapeutics Institute Inc | 1 | 1 | 0 | 0 | €0.53 | €1.70 | 223.810% |
| Fibrogen Inc. | 1 | 2 | 0 | 0 | €1.08 | €6.00 | 454.785% |
| Nymox Pharmaceutical Corp. | 0 | 2 | 0 | 0 | €0.23 | - | - |
| Cyclacel Pharmaceuticals Inc. | 2 | 12 | 0 | 0 | €0.22 | €14.66 | 6565.591% |
| Karyopharm Therapeutics Inc. | 8 | 2 | 1 | 0 | €1.01 | €5.54 | 447.437% |
| Roche Holding AG ADR | 2 | 1 | 0 | 0 | €29.04 | €38.00 | 30.874% |
| Palatin Technologies Inc. | 0 | 4 | 0 | 0 | €2.11 | - | - |
| Novan Inc | 0 | 24 | 0 | 0 | €0.001 | - | - |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 1 | 1 | 0 | 0 | €2.81 | €30.00 | 967.616% |
| Ironwood Pharmaceuticals | 8 | 1 | 1 | 0 | €6.25 | €18.80 | 200.754% |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 0 | €2.38 | €7.00 | 194.118% |
| Formycon AG | 3 | 1 | 0 | 0 | €42.85 | €100.00 | 133.372% |
| Arrowhead Pharmaceuticals Inc. | 13 | 2 | 1 | 0 | €20.45 | €49.32 | 141.193% |
| NanoCarrier Co Ltd | 0 | 1 | 0 | 0 | €0.76 | - | - |
| Neptune Wellness Solutions Inc | 0 | 13 | 0 | 0 | €0.14 | - | - |
| AEterna Zentaris Inc. | 3 | 19 | 0 | 0 | €1.87 | €14.02 | 649.759% |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €1.79 | €3.00 | 67.691% |
| Shin Nippon Biomedical Laboratories Ltd. | 0 | 1 | 0 | 0 | €8.15 | - | - |